Ipsen
Ipsen SA engages in the research, development, manufacture, and sale of pharmaceutical products worldwide.
Market cap
$9.4b
Enterprise value
$9.1b
Share price
€101.10 IPN.PA
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | €500m | Post IPO Debt |
| Total Funding | 000k | ||
No items found
No investors found
| EUR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 2 % | 15 % | 5 % | 8 % | 4 % | 6 % | 7 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 40 % | 38 % | 19 % | 38 % | 35 % | 35 % | 34 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 24 % | 21 % | 19 % | 10 % | 17 % | 18 % | 19 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 15 % | 14 % | 19 % | 19 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
ACQUISITION by Ipsen Jan 2023
ACQUISITION by Ipsen Feb 2019
ACQUISITION by Ipsen Jun 2008
ACQUISITION by Ipsen Jun 2022
exited
ACQUISITION by Ipsen Jul 2013
ACQUISITION by Ipsen Feb 2015
ACQUISITION by Ipsen Jun 2015
